|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Veterinary invoice expense | |||||
| Other cost of revenue | |||||
| Total cost of revenue | |||||
| Technology and development | |||||
| General and administrative | |||||
| New pet acquisition expense | |||||
| Goodwill, Impairment Loss | |||||
| Depreciation and amortization | |||||
| Total operating expenses | |||||
| Loss from investment in joint venture | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Other (income), net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Earnings Per Share, Basic | |||||
| Earnings Per Share, Diluted | |||||
| Weighted Average Number of Shares Outstanding, Basic | |||||
| Weighted Average Number of Shares Outstanding, Diluted | |||||
Loading...
